MedTrace Logo

Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis

NCT02873468 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2023-02-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of three doses of Florence oral suspension on changes of eosinophilic infiltration in esophageal biopsies.

Conditions

  • Eosinophilic Esophagitis

Interventions

DRUG

Florence 30 μg/mL

10 mL, oral, twice a day.

DRUG

Florence 60 μg/mL

10 mL, oral, twice a day.

DRUG

Florence 90 μg/mL

10 mL, oral, twice a day.

OTHER

Placebo

10 mL, oral, twice a day.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2025-07-31
Completion
2025-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873468 on ClinicalTrials.gov